Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study

Background: Acute leukemias are the most frequent malignancies in children. Advances in treatment have improved the overall survival to 80%. Almost 10% of children with cancer develop clinical cardiac toxicity. Total anthracycline cumulative dose is a risk factor for early-onset cardiotoxicity.Obje...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Colombia Médica
Asıl Yazarlar: Adriana Linares Ballesteros, Roy Sanguino Lobo, Juan Camilo Villada Valencia, Oscar Arévalo Leal, Diana Constanza Plazas Hernández, Nelson Aponte Barrios, Iván Perdomo Ramírez
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Universidad del Valle 2021
Konular:
Medicina
Child
leukemia
drug therapy
anthracyclines
echocardiography
Online Erişim:https://www.redalyc.org/articulo.oa?id=28366572004
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller